Results · Apr-Jun 2026 · filed 14 Aug 2026
Anupam Rasayan India Q1 FY27 results
Sales grew 35% to ₹655 crore from ₹486 crore in Apr-Jun 2025.
Operating profit grew 31% to ₹162 crore, an operating margin of 24.8% (down 0.8 points from a year ago).
Net profit grew 6% to ₹51.2 crore from ₹48.5 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +3%, net profit −9%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 655.0 | 485.8 | +35% |
| Operating profit (EBITDA) | 162.4 | 124.3 | +31% |
| Operating margin | 24.8% | 25.6% | −0.8 pts |
| Net profit | 51.2 | 48.5 | +6% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Anupam Rasayan reported Apr–Jun 2026 consolidated total income of ₹668 crore, up 36% year-on-year, with EBITDA at ₹175 crore (26% margin). The company commercialized ETFA using flow chemistry & signed a USD300 million LOI with BASQUEVOLT, signaling progress on its strategy to build a diversified specialty chemicals platform through acquisitions & new product launches.
The last 7 quarters
Filings that week
- 20 Aug 2026Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- 17 Aug 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- 15 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 14 Aug 2026Financial Results For The Quarter Ended June 30, 2026.
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.